SCHEDULE 13G/A

Statement of Beneficial Ownership

Prelude Therapeutics Inc Filed 2025-05-15 Acc 0000929638-25-001925

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)